Navigation Links
Nektar Therapeutics Reports Third Quarter 2011 Financial Results
Date:11/2/2011

181, a novel mu-opioid analgesic molecule wholly-owned by Nektar, is being evaluated in Phase 1 clinical studies.  In oncology, NKTR-102, a novel proprietary topoisomerase I-inhibitor, is being evaluated in Phase 2 clinical studies for the treatment of breast, ovarian and colorectal cancers.

Nektar's technology has enabled seven approved products in the U.S. or Europe through partnerships with leading biopharmaceutical companies, including UCB's Cimzia® for Crohn's disease and rheumatoid arthritis, Roche's PEGASYS® for hepatitis C and Amgen's Neulasta® for neutropenia. Additional development stage products that leverage Nektar's proprietary technology platform include peginesatide, for which Affymax and partner Takeda submitted an NDA to the FDA in May 2011, and Baxter's BAX 855, a long-acting PEGylated rFVIII program planned to enter Phase 1 clinical development in 2011.

Nektar is headquartered in San Francisco, California, with additional R&D operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

This press release contains forward-looking statements including but not limited to Nektar's plans to initiate the Phase 3 BEACON study for NKTR-102 in metastatic breast cancer before year-end, plans to complete a Phase 1 clinical study for NKTR-181 and announce those results before year end, AstraZeneca's plans for regulatory filings in 2013, Baxter's plans to advance BAX 855 into Phase 1 clinical development prior to year end, Nektar's plan to file an investigational new drug application for NKTR-192 in the first quarter of 2012, and the value and potential of Nektar's R&D pipeline.  These forward-looking statements involve numerous risks and uncertainties, including but not limited to: (i) Nektar's product candidates and those of its collaborati
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
4. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
5. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
6. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
7. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
8. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
9. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
10. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
11. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014 The number ... killing 45 people each day. Twenty-three percent of the ... Survey on Drug Use and Health, making opioid use ... are taking opioid painkillers at the correct dosage with ... Today, the National Safety Council ...
(Date:7/22/2014)... VIEW, Calif. , July 22, 2014 /PRNewswire/ ... resonance imaging (MRI) market, Frost & Sullivan recognizes ... for Product Leadership. Siemens Healthcare,s FREEZEit solution, which ... the need for robust and motion-insensitive imaging. The ... boosted the evolution of body MRI imaging in ...
(Date:7/22/2014)... -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN ... first lots of Fluzone ® (Influenza Vaccine) for the ... U.S. Food and Drug Administration (FDA) for distribution. The lots ... at least 65 million doses of seasonal influenza vaccine manufactured ... care providers and pharmacies in August. The ...
Breaking Medicine Technology:5 things employers should know about prescription painkiller use 25 things employers should know about prescription painkiller use 3Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 2Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 3Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 4Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 2Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 3Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 4Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 5Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 6Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 7
... LAKE FOREST, Ill., Feb. 14, 2011 Hospira, Inc. (NYSE: ... delivery company, today announced that the company will present at ... Institutional Investors Conference March 8, 2011 ... Barclays Capital 2011 Global Healthcare Conference ...
... Calif., Feb. 14, 2011 / PRNewswire/ -- ... a $22 million Series D financing round led by ... were Split Rock Partners, Legacy Life Sciences, EDF Ventures, ... Asset Management Partners.  In connection with the financing, Dr. ...
Cached Medicine Technology:Sonoma Orthopedic Products® Closes $22 Million Series D Financing 2
(Date:7/23/2014)... GA (PRWEB) July 23, 2014 ... manufacturer located in Lawrenceville, Georgia, welcomed Andreas von Uexkull ... his tour of the U.S. von Uexkull, a top ... an extended tour of the U.S. to bring awareness ... Trans-Atlantic Trade and Investment Partnership (TTIP). , As ...
(Date:7/23/2014)... On July 4th, at the age of 70, Kitty ... first place prize in her age group at the Firecracker 5K ... until she was in her forties before becoming an ordained minister ... running. Not one to do anything halfway, she launched her running ... the decision to begin running started five years ago at the ...
(Date:7/22/2014)... Ticket Down is a reliable source for ... at Sporting Park in Kansas City, MO. This friendly ... Tickets can be conveniently printed out for this exciting match ... reached toll free at 1-877-870-3653. All tickets for Sporting ... Ticket Down's customer satisfaction guarantee. , About TicketDown.com: , ...
(Date:7/22/2014)... July 23, 2014 Provectus ... . From now on, in addition to working with ... solutions for Google Glass as well as the creation ... , A dynamic lifestyle requires special gadgets for work, ... has found application in healthcare, logistics, travelling, sports, education, ...
(Date:7/22/2014)... 22, 2014 Obtaining a bachelor’s degree ... veterans who have hands-on medical experience. The School of ... today announced the launch of an accelerated nursing degree ... The new program, the UNCG Veterans Access Program (VAP), ... 24 veterans. With some prior college credit, veterans who ...
Breaking Medicine News(10 mins):Health News:Swedish Official Tours PartnerTech’s U.S. Facility 2Health News:Swedish Official Tours PartnerTech’s U.S. Facility 3Health News:Naperville, Ilinois’ Monarch Landing Resident Wins First Place in 5K Run 2Health News:Sporting Kansas City vs. Manchester City Tickets: Ticket Down Has Slashed Ticket Prices for Manchester City vs. Sporting Kansas City on July 23rd 2Health News:Provectus Announces Development for Google Glass and Wearables 2Health News:UNCG School of Nursing Fast-Tracks Medically Trained Veterans 2
... 2011) The kidney performs several vital functions. It ... the body,s fluids, and releases hormones that regulate blood ... the kidney,s filtration apparatus, such as diabetes and immune ... syndrome, which is characterized by protein in the urine, ...
... Reporter , THURSDAY, Sept. 22 (HealthDay News) -- From hide-and-seek ... of the hallmarks of childhood. But in this era of ... have far less time to play than kids of ... for their development and mental health. "Into the 1950s, ...
... RELEASE,Sept. 21, 2011 INDIANAPOLIS, Ind. -- Dena S. ... the Kelley School of Business Indianapolis, has received a ... influencing young women,s adoption of the human papillomavirus (HPV) ... decisions, examining the effects of health communication on consumers, ...
... method for simultaneously visualizing gene number and protein expression ... a detailed analysis of the relationship between gene status ... tissues, and bring a clearer understanding of cancer and ... study. The new technique is called the fluorescent in ...
... HealthDay Reporter , WEDNESDAY, Sept. 21 (HealthDay News) -- ... a leading cause of diarrhea in infants and young children ... and about $278 million in healthcare costs have been saved, ... a common and easily transmitted pathogen. The new study, from ...
... Reporter , WEDNESDAY, Sept. 21 (HealthDay News) -- Waiting ... risk of death and hospitalization in people with kidney ... to die or head to the hospital for cardiovascular-related ... sessions compared to a one-day gap, concluded researchers from ...
Cached Medicine News:Health News:Kidney damage and high blood pressure 2Health News:Less Play Time = More Troubled Kids, Experts Say 2Health News:Less Play Time = More Troubled Kids, Experts Say 3Health News:Indiana U. professor to examine how women respond to information about the HPV vaccine 2Health News:Novel technique reveals both gene number and protein expression simultaneously 2Health News:Vaccine for Childhood Diarrhea Helps Kids, Saves Dollars 2Health News:Vaccine for Childhood Diarrhea Helps Kids, Saves Dollars 3Health News:Two-Day Dialysis Interval Could Pose Danger: Study 2Health News:Two-Day Dialysis Interval Could Pose Danger: Study 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: